Abstracts

VISUALIZATION OF HIV-1 CAPSID-DEPENDENT REPLICATION IN VITRO

HIV-1 initiates receptor-mediated entry of the virus core particle into the cytoplasm of a host cell. This core particle is organized by a fullerene capsid shell, which houses the viral RNA genome and its associated replicative enzymes. Upon entry, the capsid facilitates reverse transcription, shields the viral nucleic acids from host defense sensors, and coordinates…

IMMUNE EVASION STRATEGIES BY SARS-CoV-2: Nsp1 AND BEYOND

The human innate immune system represents a powerful first line of antiviral defenses. Incoming viral pathogens are quickly detected by dedicated germ-line encoded sensors, called pattern recognition receptors. For example, intracellular RNA viruses, like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are detected by RIG-like receptors such as RIG-I and MDA5. Activation of these…

IMMUNE RESPONSES TO SARS-CoV-2

The clinical presentation of COVID-19 involves a broad range of symptoms and disease trajectories. Understanding the nature of the immune response that leads to recovery over severe disease is key to developing effective treatments for COVID-19. In this talk, I will discuss immune responses in COVID-19 patients with moderate and severe disease. I will compare…

DOES HIV IMPACT COVID-19 SUSCEPTIBILITY OR SEVERITY?

In the early days of the COVID-19 pandemic, the HIV community became preoccupied that COVID-19 could be more severe in people with HIV (PWH) because of immunodeficiency, higher prevalence of comorbidities and immunosenescence, which had been associated with poorer COVID-19 outcomes. Nonetheless, HIV was not initially identified as disproportionally prevalent in hospitalized patients with COVID-19,…